Aspire Biopharma (ASBP) announced positive initial consumer feedback from the Company’s sampling of its sublingual pre-workout supplement, BUZZ BOMB. Featuring 50mg of caffeine and designed to support sustained energy and mental focus, BUZZ BOMB is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout market to help athletes and fitness enthusiasts maximize their performance potential. Last month, BUZZ BOMB began a soft launch of its product line, introducing it to strength trainers, consultants, and fitness professionals. Aspire sees BUZZ BOMB as more than just another supplement; it is a science-driven brand focused on understanding nutrition, performance, and the daily needs of athletes and fitness enthusiasts. BUZZ BOMB is a pre-workout solution that boosts endurance, energy metabolism, and overall performance, primarily through caffeine, a well-researched ingredient shown to enhance fitness results. Unlike pre-workout products that are mixed with water and taken well before a workout, BUZZ BOMB is sprinkled under the tongue for immediate effect.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASBP:
